Cargando…

Identifying the top research priorities in postmastectomy breast cancer reconstruction: a James Lind Alliance priority setting partnership

BACKGROUND: Major improvements in breast cancer treatment in the last decade include advancements in postmastectomy breast reconstruction (PMBR). Unfortunately, the studies in PMBR are primarily researcher or industry led with minimal input from patients and caregivers. The aim of this study is to u...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Toni, Mahajan, Anisha, Cowan, Katherine, Temple-Oberle, Claire, Porter, Geoff, LeBlanc, Martin, Metcalfe, Kelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407216/
https://www.ncbi.nlm.nih.gov/pubmed/34462280
http://dx.doi.org/10.1136/bmjopen-2020-047589
_version_ 1783746607100985344
author Zhong, Toni
Mahajan, Anisha
Cowan, Katherine
Temple-Oberle, Claire
Porter, Geoff
LeBlanc, Martin
Metcalfe, Kelly
author_facet Zhong, Toni
Mahajan, Anisha
Cowan, Katherine
Temple-Oberle, Claire
Porter, Geoff
LeBlanc, Martin
Metcalfe, Kelly
author_sort Zhong, Toni
collection PubMed
description BACKGROUND: Major improvements in breast cancer treatment in the last decade include advancements in postmastectomy breast reconstruction (PMBR). Unfortunately, the studies in PMBR are primarily researcher or industry led with minimal input from patients and caregivers. The aim of this study is to use the James Lind Alliance (JLA) approach to bring together the patients, caregivers and clinicians in a priority setting partnership to identify the most important unanswered research questions in PMBR. METHODS: The JLA priority setting methodology involved four key stages: gathering research questions on PMBR from patients, caregivers and clinicians; checking these research questions against existing evidence; interim prioritisation and a final consensus meeting to determine the top 10 unanswered research questions using the modified nominal group methodology. RESULTS: In stage 1, 3168 research questions were submitted from 713 respondents across Canada, of which 73% of the participants were patients or caregivers. Stage 2 confirmed that there were a total of 48 unique unanswered questions. In stage three, 488 individuals completed the interim prioritisation survey and the top 25 questions were taken to a final consensus meeting. In the final stage, the top 10 unanswered research questions were determined. They cover a breadth of topics including personalised surgical treatment, safety of implants and newer techniques, access to PMBR, breast cancer recurrence and rehabilitation. INTERPRETATION: Identification of the top 10 unanswered research questions is an important first step to generating relevant and impactful research that will ultimately improve the PMBR experience for patients with breast cancer.
format Online
Article
Text
id pubmed-8407216
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-84072162021-09-16 Identifying the top research priorities in postmastectomy breast cancer reconstruction: a James Lind Alliance priority setting partnership Zhong, Toni Mahajan, Anisha Cowan, Katherine Temple-Oberle, Claire Porter, Geoff LeBlanc, Martin Metcalfe, Kelly BMJ Open Oncology BACKGROUND: Major improvements in breast cancer treatment in the last decade include advancements in postmastectomy breast reconstruction (PMBR). Unfortunately, the studies in PMBR are primarily researcher or industry led with minimal input from patients and caregivers. The aim of this study is to use the James Lind Alliance (JLA) approach to bring together the patients, caregivers and clinicians in a priority setting partnership to identify the most important unanswered research questions in PMBR. METHODS: The JLA priority setting methodology involved four key stages: gathering research questions on PMBR from patients, caregivers and clinicians; checking these research questions against existing evidence; interim prioritisation and a final consensus meeting to determine the top 10 unanswered research questions using the modified nominal group methodology. RESULTS: In stage 1, 3168 research questions were submitted from 713 respondents across Canada, of which 73% of the participants were patients or caregivers. Stage 2 confirmed that there were a total of 48 unique unanswered questions. In stage three, 488 individuals completed the interim prioritisation survey and the top 25 questions were taken to a final consensus meeting. In the final stage, the top 10 unanswered research questions were determined. They cover a breadth of topics including personalised surgical treatment, safety of implants and newer techniques, access to PMBR, breast cancer recurrence and rehabilitation. INTERPRETATION: Identification of the top 10 unanswered research questions is an important first step to generating relevant and impactful research that will ultimately improve the PMBR experience for patients with breast cancer. BMJ Publishing Group 2021-08-29 /pmc/articles/PMC8407216/ /pubmed/34462280 http://dx.doi.org/10.1136/bmjopen-2020-047589 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Oncology
Zhong, Toni
Mahajan, Anisha
Cowan, Katherine
Temple-Oberle, Claire
Porter, Geoff
LeBlanc, Martin
Metcalfe, Kelly
Identifying the top research priorities in postmastectomy breast cancer reconstruction: a James Lind Alliance priority setting partnership
title Identifying the top research priorities in postmastectomy breast cancer reconstruction: a James Lind Alliance priority setting partnership
title_full Identifying the top research priorities in postmastectomy breast cancer reconstruction: a James Lind Alliance priority setting partnership
title_fullStr Identifying the top research priorities in postmastectomy breast cancer reconstruction: a James Lind Alliance priority setting partnership
title_full_unstemmed Identifying the top research priorities in postmastectomy breast cancer reconstruction: a James Lind Alliance priority setting partnership
title_short Identifying the top research priorities in postmastectomy breast cancer reconstruction: a James Lind Alliance priority setting partnership
title_sort identifying the top research priorities in postmastectomy breast cancer reconstruction: a james lind alliance priority setting partnership
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407216/
https://www.ncbi.nlm.nih.gov/pubmed/34462280
http://dx.doi.org/10.1136/bmjopen-2020-047589
work_keys_str_mv AT zhongtoni identifyingthetopresearchprioritiesinpostmastectomybreastcancerreconstructionajameslindallianceprioritysettingpartnership
AT mahajananisha identifyingthetopresearchprioritiesinpostmastectomybreastcancerreconstructionajameslindallianceprioritysettingpartnership
AT cowankatherine identifyingthetopresearchprioritiesinpostmastectomybreastcancerreconstructionajameslindallianceprioritysettingpartnership
AT templeoberleclaire identifyingthetopresearchprioritiesinpostmastectomybreastcancerreconstructionajameslindallianceprioritysettingpartnership
AT portergeoff identifyingthetopresearchprioritiesinpostmastectomybreastcancerreconstructionajameslindallianceprioritysettingpartnership
AT leblancmartin identifyingthetopresearchprioritiesinpostmastectomybreastcancerreconstructionajameslindallianceprioritysettingpartnership
AT metcalfekelly identifyingthetopresearchprioritiesinpostmastectomybreastcancerreconstructionajameslindallianceprioritysettingpartnership